CARGO Therapeutics, Inc. Common StockCRGXNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank33
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P33
Within normal range
vs 2Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | 89.20% |
| 2023 | 158.03% |
| 2022 | 558.44% |
| 2021 | 0.00% |